Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02393690
Title Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
UC San Diego Moores Cancer Center La Jolla California 92093 United States Details
Hoag Memorial Hospital Newport Beach California 92663 United States Details
University of Colorado Hospital Aurora Colorado 80045 United States Details
MedStar Georgetown University Hospital Washington District of Columbia 20007 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232 United States Details
M D Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field